According to research presented in a paper published in 2005, quercetin could increase KB-V1 cells from human cervical carcinoma to paclitaxel and vinblastine, as well as decrease their relative resistance to these two anticancer agents in KB-V1 cells, which had a high plasma membrane P-glycoproteins and multidrug-resistant properties. The gene discussed is ABCB1; the disease is cervical carcinoma.